| 39 |
Lee, C. H., Han, S. R., and Lee, S.-W. (2018) Group I intron-based therapeutics through trans-splicing reaction. Progress in Molecular Biology and Translational Science 159: 79-100. |
|
| 38 |
Lee, C. H., Han, S. R., and Lee, S.-W. (2018) Therapeutic applications of group I intron-based trans-splicing ribozymes. WIREs RNA 9(3): e1466. |
|
| 37 |
Kim, S. J., Kim, J. H., Yang, B., Jeong, J.-S., and Lee, S.-W. (2017) Specific and efficient regression of cancers harboring KRAS mutation by targeted RNA replacement. Molecular Therapy 25(2): 356-367. |
|
| 36 |
Kim, Y.-H., Kim, K. T., Lee, S.-J., Hong, S.-H., Moon, J. Y., Yoon, E. K., Kim, S., Kim, E. O., Kang, S. H., Kim, S. K., Choi, S. I., Goh, S. H., Kim, D., Lee, S.-W., Ju, M. H., Jeong, J. S., and Kim, I.-H. (2016) Image-guided suicide gene therapy utilizi |
|
| 35 |
Won, Y. S., Jeong, J.-S., Kim, S. J., Ju, M. H., and Lee, S.-W. (2015) Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement. Cancer Letters 356(2): 918-928. |
|
| 34 |
Kim, J., Won, R., Ban, G., Ju, M. H., Cho, K. S., Han, S. Y., Jeong, J.-S., and Lee, S.-W. (2015) Targeted regression of hepatocellular carcinoma by cancer-specific RNA replacement through microRNA regulation. Scientific Reports 5, 12315. |
|
| 33 |
Kim, S. J., and Lee, S.-W. (2014) Selective expression of transgene using hypoxia-inducible trans-splicing group I intron ribozyme. Journal of Biotechnology 192: 22-27. |
|
| 32 |
Kim, J., Jeong, S., Kertsburg, A., Soukup, G. A., and Lee, S.-W. (2014) Conditional and target-specific transgene induction through RNA replacement using an allosteric trans-splicing ribozyme. ACS Chemical Biology 9(11): 2491-2495. |
|
| 31 |
Kim, Y.-H., Moon, J. Y., Kim, E.-O., Lee, S. J., Kang, S.H., Kim, S. K., Heo, K., Lee, Y., Kim, H., Kim, K. T., Kim, D., Song, M. S., Lee, S.-W., Lee, Y., Koh, S. S., and Kim, I.-H. (2014) Efficient targeting and tumor retardation effect of pancreatic ade |
|
| 30 |
Lee, S.-W., and Jeong J. S. (2014) Use of tumor-targeting trans-splicing ribozyme for cancer treatment. Methods in Molecular Biology 1103: 83-95. |
|
